How to Check a Plan for GLP-1 Coverage Before You Enroll
Author
Date Published
- Twitter
- Facebook
- LinkedIn
- Instagram
- Copy Link
Employers are dropping weight-loss coverage for these medications, though health condition-specific coverage may stay the same, and open enrollment is the one window where you can do something about it. The check takes about twenty minutes: find the plan's drug list, look up the specific medication by name, and read what conditions are attached. Doing that before you pick beats finding out at the pharmacy counter in January. If you qualify for these medications due to a health condition, this check will still benefit you as the criteria is listed in the same space regardless.
Who This Helps
This is for you if you take a GLP-1 for weight loss, or want to, and you're choosing a plan this fall. Employer enrollment usually runs through the fall, and the marketplace runs November 1 to January 15 (HealthCare.gov). If your coverage has already ended, our piece on what happens when you stop covers that side.
How much coverage has actually moved
Get the risk of losing coverage straight before assuming the worst or the best.
- Large employers were never the majority. In 2025, 19% of firms with 200 or more workers covered GLP-1s for weight loss, rising to 43% among firms with 5,000 or more (KFF).
- Most who cover it intend to keep it. In a survey of 105 large employers early in 2026, 67% covered the drugs for weight management, 72% said they would likely continue through 2027, and 10% said they likely would not (Business Group on Health).
- Conditions are tightening faster than coverage is vanishing. Among firms that cover these medications, the share requiring enrollees to work with a dietitian, case manager or lifestyle program jumped to 34% in 2025 from 10% the year before (KFF).
- The effect is visible in prescriptions. First-time prescribing of semaglutide for weight management fell 13.3% between March and June 2026 (Truveta), though it may not be entirely due to insurance pressure.
One state shows what a sharp drop looks like. In Massachusetts, 112,000 fewer commercially insured members used one of these drugs for weight loss between 2025 and early 2026, a 52% decline, after several major plans dropped the benefit (WGBH). Coverage for diabetes continued. That split, weight loss dropped and diabetes kept, is the most common pattern.
The twenty-minute check
Do this for every plan you are considering, before you rank them.
- Find the formulary, not the brochure. The summary of benefits won't tell you. Ask for the prescription drug list or formulary, which is a separate document. On the marketplace, plan details link to it from the plan comparison tool (HealthCare.gov).
- Search the exact brand name. Not "GLP-1" and not the ingredient. Wegovy and Zepbound are listed separately from the diabetes versions of the same molecules, and a plan can cover one and not the other.
- Read the tier and the footnotes. A drug can appear on the list and still require prior authorization, a BMI threshold, documented attempts at other approaches, or enrollment in a lifestyle program. Those conditions are where most denials come from.
- Check for a category exclusion. This is the important distinction. If a plan excludes weight-loss medications as a category and you do not have the qualifying conditions, the drug isn't on the list at all and an appeal is very hard, because nothing was denied on medical grounds. If the drug is listed but restricted, an appeal is a real path.
- Call and get it in writing. Ask the plan directly: is this drug covered for weight management, what are the requirements, and what is my cost at each tier. Ask your HR benefits contact the same question for an employer plan.
Find a provider in your state
Answer a few questions and see live pricing from the providers that ship where you live.
Marketplace, Medicaid and employer plans work differently
Marketplace plans vary by state. Weight-loss medications aren't a federally required benefit, so whether they are covered depends on your state's benchmark plan, which is why it’s especially tricky to get coverage for weight loss alone. Two plans on the same exchange can differ, which is why the formulary check matters more here than anywhere else.
Medicaid coverage is shrinking. Thirteen state programs covered these medications for obesity as of January 2026, down from sixteen the previous October (KFF).
Employer plans carry the appeal rights most people actually have. Under federal rules, a plan must decide an urgent claim within 72 hours, a pre-service claim within 15 days and a post-service claim within 30 days, and you have a right to external review after an internal denial (US Department of Labor). On a marketplace plan, you have 180 days from the denial to file an internal appeal, and four months to request external review (HealthCare.gov).
Three things people assume that aren't true
- A diabetes diagnosis doesn't guarantee coverage. It usually helps a lot, because the diabetes indication is covered far more often than the weight one. It's still a plan-by-plan question.
- Covered last year doesn't mean covered next year. Formularies change annually (some can change mid-year!), and for employer and marketplace plans there's no general federal requirement for a transition fill or advance notice of a mid-year formulary change. That protection exists in Medicare Part D and doesn't carry over.
- The savings card isn't for everyone. Manufacturer copay cards generally exclude people with government coverage, and many manufacturers are phasing them out for GLP-1s. Self-pay pricing is a different thing and it's open to more people: Novo Nordisk currently lists the Wegovy pen at $349 a month for standard doses after an introductory period (NovoCare).
If coverage is gone anyway
Manufacturer self-pay pricing is the main route, and worth pricing against your plan's copay rather than assuming insurance wins. A compounded product prepared by a licensed pharmacy for a documented clinical need is another path your prescriber may take, and our guide to how 503A and 503B pharmacies differ covers what to check about the pharmacy.
On tax-advantaged accounts (like FSA/HSA accounts), the rule is narrower than people think. The IRS treats weight-loss costs as a medical expense "only if the program treats a specific disease diagnosed by a physician (such as obesity, diabetes, hypertension, or heart disease)" (IRS). A prescribed medication for a diagnosed condition generally qualifies. General wellness spending doesn't.
If you're comparing what different providers charge before you decide, our provider comparison survey shows live pricing by state and dose.
Final Takeaway
Coverage for these medications is being narrowed rather than eliminated for many plans, and the narrowing is mostly happening through conditions rather than outright exclusions. That's good news in one respect: conditions can be documented if you qualify, and they're written down in advance. Your task now is doing the check before you enroll instead of after. Pull the drug list for every plan you are considering, search the exact brand name, read what is attached to it, and call if anything is ambiguous. Twenty minutes in October is worth a great deal more than an appeal in February.
If you enjoy posts like these, you can subscribe to receive newsletter updates.
Frequently Asked Questions
How do I find out if a health plan covers Wegovy or Zepbound?
Ask for the plan's prescription drug list, sometimes called the formulary, which is a separate document from the summary of benefits. Search it for the exact brand name rather than the ingredient, then read the footnotes for prior authorization, BMI thresholds or program requirements. Call the plan if anything is unclear and ask for the answer in writing.
Are weight-loss drugs covered on marketplace plans?
It depends on your state. These medications aren't a federally required benefit, so coverage follows your state's benchmark plan, and two plans on the same exchange can differ. The formulary is the only reliable way to tell.
What if my plan drops coverage in the middle of the year?
For employer and marketplace plans there's no general federal requirement for a transition fill or advance notice, so the practical steps are to ask whether a formulary exception is available, file an appeal if the drug is listed but restricted, and price the manufacturer self-pay option in the meantime.
Find a provider in your state
Answer a few questions and see live pricing from the providers that ship where you live.
Keep Reading
What Medicare, insurance, and federal policy signals really mean for GLP-1 coverage in 2026, including access rules, costs, and eligibility.
Learn what’s changing in 2026 insurance plans for GLP-1 drugs and how to compare costs, coverage, and plan options to stay protected.
Prescription approved but insurance said no? Learn your next options for Wegovy, Ozempic, or Zepbound coverage and care.
Categories
Written by
Lauren PescarusLauren Pescarus is a team member with GLP Winner where she works on marketing, content creation, and operations. She has over 10 years experience in the content creation space, including in the GLP-1 space where she works to stay on top of access news, research updates, and lifestyle tips guided by science.